小児急性中耳炎の起因菌の変化と治療 Changes in Causative Bacteria of Pediatric Acute Otitis Media

この論文にアクセスする

この論文をさがす

著者

抄録

In 2001 and 2004-2005, in cooperation with clinics in the Johnan area in Tokyo, we conducted studies to evaluate bacteria isolated from epipharynx of acute otitis media patients aged 10 years old or younger. In this presentation, we report a comparison between the findings of these two studies. In addition, the results of evaluating of gene mutations in isolated bacteria and the efficacy of Cefrerm Pivoxil (CFTM-PI) in the treatment of otitis media will be discussed.<br>In 2001, 191 strains of bacteria were isolated from a total of 123 ears. These isolates included 78 strains of <i>Streptococcus pneumoniae</i> (PSSP 37 strains, PISP 38 strains, PRSP 3 strains), 59 strains of <i>Haemophilus influenzae</i> (BLNAS 49 strains, BLNAR 10 strains) and 54 strains of <i>Moraxella catarrhalis</i>. Among <i>Streptococcus pneumoniae</i> isolated, 52.6% were drug-resistant strains, and 16.9% of <i>Haemophilus influenzae</i>, showed resistance. During the study conducted between 2004 and 2005, 223 strains were isolated. These isolates included 73 strains of <i>Streptococcus pneumoniae</i> (PSSP 28 strains, PISP 28 strains, PRSP 17 strains), 67 strains of <i>Haemophilus influenzae</i> (BLNAS 43 strains, BLNAR 20 strains, BLPAR 3 strains, BLPACR 1 strain) and 61 strains of <i>Moraxella catarrhalis</i>. 61.6% of <i>Streptococcus pneumoniae</i> and 35.8% of <i>Haemophilus influenzae</i> were drug-resistant strains. On the evaluation of gene mutations, 70 strains of <i>Streptococcus pneumoniae</i> showed gene mutations; especially, <i>pbp2x</i> mutations were observed in all of the strains. As for <i>Haemophilus influenzae</i>, there were 32β-lactamase-non-producing strains and 4β-lactamase-producing strains both with pbp mutations. In the evaluation of efficacy, CFTM-PI showed good antimicrobial activity with MIC of 0.25-1μg/mL against both pbp mutated strains of <i>Haemophilus influenzae</i>. The approved dosage for CFTM-PI is 9-18mg/kg, and it has a rather wide range. In the treatment of pediatric acute otitis media, if penicillin administration is not effective, CFTM-PI seems to be a useful option considering the potential of <i>Haemophilus influenzae</i> infection and the possibility of doubling the dosage.

収録刊行物

  • 耳鼻咽喉科臨床  

    耳鼻咽喉科臨床 99(8), 635-642, 2006-08-01 

    The Society of Practical Otolaryngology

参考文献:  8件

参考文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

被引用文献:  1件

被引用文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

各種コード

  • NII論文ID(NAID)
    10018228545
  • NII書誌ID(NCID)
    AN00107089
  • 本文言語コード
    JPN
  • 資料種別
    NOT
  • ISSN
    00326313
  • NDL 記事登録ID
    8058634
  • NDL 雑誌分類
    ZS43(科学技術--医学--耳鼻咽喉科学)
  • NDL 請求記号
    Z19-421
  • データ提供元
    CJP書誌  CJP引用  NDL  J-STAGE 
ページトップへ